Description
Linagliptin Tablets Description
Product name: Linagliptin tablets
Packing specification: 5mg*7 tablets Product dosage form: tablets Packaging unit: bottle/box
Approval number: National Medicine Standard H20213378 Drug standard code: 86900841000279
Manufacturer: Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd.
Product barcode: 6931640900068
What is Linagliptin?
Linagliptin is a potent oral DPP4 (dipeptidyl peptidase4) inhibitor, used clinically to regulate blood sugar in Type2 Diabetes Mellitus (T2DM) by enhancing levels of active incretins zh.wikipedia.org+2zh.wikipedia.org+2bydrug.pharmcube.com+2pharm.ncmi.cn+12zh.wikipedia.org+12zh.wikipedia.org+12. Its therapeutic advantages include once daily dosing, low hypoglycemia risk, and no need for dosage adjustment in renal impairment due to biliary elimination.
This domestic product, marketed as HuYou or RuLing, is produced by Yangtze River Pharmaceutical Group’s Shanghai Henley Pharma, under NMPA approval number H20213378 with product code 86900841000279 and barcode 6931640900068.
Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Linagliptin Tablets (HuYou/RuLing) |
| Strength | 5mg per tablet |
| Quantity | 7 tablets per bottle |
| Dosage Form | Film-coated oral tablets |
| Approval No. (NMPA) | H20213378 |
| Pharmaceutical Product Code | 86900841000279 |
| Manufacturer | Shanghai Henley Pharma (Yangtze River Pharmaceutical Group) |
| Barcode | 6931640900068 |
| Shelf Life | 24 months |
| Storage Conditions | Store in cool, dry place below 30°C |
| Intended Use | Laboratory research or analytical use only |
Mechanism of Action & Key Benefits
Selective DPP4 Inhibition: Increases endogenous GLP-1 and GIP, promoting insulin secretion and suppressing glucagon in a glucose-dependent way.
Pharmacokinetics: High oral bioavailability (~30%), strong plasma protein binding (75–99%), and long half-life enable once-daily dosing.
Renal Safety: Cleared mainly via bile; no dose adjustment needed in renal impairment.
Clinical Tolerability: Minimal hypoglycemia when used alone; mild adverse events may include headache or upper respiratory infections.
Why Choose HuYou/RuLing Linagliptin?
Reputable Manufacturer: Produced by Yangtze River Pharmaceutical Group
Approved & Traceable: NMPA-approved with full batch traceability
Lab-ready Packaging: 7-tablet bottles ideal for study protocols
Research-grade Quality: Consistent formulation and documentation for pharmacological studies
Sitagliptin Phosphate Tablets (100mg) – Jianovi
Vildagliptin Tablets (Weitangning 50mg)
Empagliflozin 10mg Tablets (SGLT2 Inhibitor)
Summary
HuYou/RuLing Linagliptin 5mg Tablets provide a high-quality research-grade DPP4 inhibitor option with robust production credentials, stable packaging, and full regulatory traceability. Ideal for labs exploring metabolic and endocrine research.
Reminder: For laboratory research or analytical use only — not for human consumption or therapy.


kristin –
Waiting for the package, thank you